Needham & Company Maintains a 'Buy' on OncoGenex Pharmaceuticals (OGXI); Custersin and OGX-427 Development Remain on Track
Go back to Needham & Company Maintains a 'Buy' on OncoGenex Pharmaceuticals (OGXI); Custersin and OGX-427 Development Remain on Track| OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) | Delayed: 0.40 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.40 | 52 Week High | $2.80 | |||
| Open | $0.05 | 52 Week Low | $0.33 | |||
| Day High | $0.40 | P/E | N/A | |||
| Day Low | $0.40 | EPS | $-1.98 | |||
| Volume | 500 | |||||
